249 related articles for article (PubMed ID: 16831294)
1. Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alpha.
Ogilvie AL; Lüftl M; Antoni C; Schuler G; Kalden JR; Lorenz HM
Int J Immunopathol Pharmacol; 2006; 19(2):271-8. PubMed ID: 16831294
[TBL] [Abstract][Full Text] [Related]
2. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
Markham T; Mullan R; Golden-Mason L; Rogers S; Bresnihan B; Fitzgerald O; Fearon U; Veale DJ
J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
[TBL] [Abstract][Full Text] [Related]
3. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G
J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
[TBL] [Abstract][Full Text] [Related]
4. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.
Johansen C; Funding AT; Otkjaer K; Kragballe K; Jensen UB; Madsen M; Binderup L; Skak-Nielsen T; Fjording MS; Iversen L
J Immunol; 2006 Feb; 176(3):1431-8. PubMed ID: 16424170
[TBL] [Abstract][Full Text] [Related]
5. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.
Johansen C; Vinter H; Soegaard-Madsen L; Olsen LR; Steiniche T; Iversen L; Kragballe K
Br J Dermatol; 2010 Dec; 163(6):1194-204. PubMed ID: 20846304
[TBL] [Abstract][Full Text] [Related]
6. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
[TBL] [Abstract][Full Text] [Related]
7. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
[TBL] [Abstract][Full Text] [Related]
8. Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate.
Ogilvie AL; Antoni C; Dechant C; Manger B; Kalden JR; Schuler G; Lüftl M
Br J Dermatol; 2001 Mar; 144(3):587-9. PubMed ID: 11260020
[TBL] [Abstract][Full Text] [Related]
9. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
[TBL] [Abstract][Full Text] [Related]
10. CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin.
Brunner PM; Glitzner E; Reininger B; Klein I; Stary G; Mildner M; Uhrin P; Sibilia M; Stingl G
Exp Dermatol; 2015 Jul; 24(7):522-8. PubMed ID: 25828150
[TBL] [Abstract][Full Text] [Related]
11. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR
J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177
[TBL] [Abstract][Full Text] [Related]
12. Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis.
Victor FC; Gottlieb AB; Menter A
Clin Dermatol; 2003; 21(5):392-7. PubMed ID: 14678719
[TBL] [Abstract][Full Text] [Related]
13. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
Oxholm A
APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
[TBL] [Abstract][Full Text] [Related]
14. Elevated leukaemia inhibitory factor (LIF) expression in lesional psoriatic skin: correlation with interleukin (IL)-8 expression.
Szepietowski J; Walker C; Hunter JA; McKenzie RC
J Dermatol; 2001 Mar; 28(3):115-22. PubMed ID: 11349461
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
[TBL] [Abstract][Full Text] [Related]
16. Cytokine expression, upregulation of intercellular adhesion molecule-1, and leukocyte infiltration in experimental tubulointerstitial nephritis.
Tang WW; Feng L; Mathison JC; Wilson CB
Lab Invest; 1994 May; 70(5):631-8. PubMed ID: 7910873
[TBL] [Abstract][Full Text] [Related]
17. Infliximab in psoriasis and psoriatic arthritis.
Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A
BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
[TBL] [Abstract][Full Text] [Related]
18. Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions.
Kokolakis G; Giannikaki E; Stathopoulos E; Avramidis G; Tosca AD; Krüger-Krasagakis S
Br J Dermatol; 2012 Mar; 166(3):491-7. PubMed ID: 21985184
[TBL] [Abstract][Full Text] [Related]
19. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response.
Uyemura K; Yamamura M; Fivenson DF; Modlin RL; Nickoloff BJ
J Invest Dermatol; 1993 Nov; 101(5):701-5. PubMed ID: 7693825
[TBL] [Abstract][Full Text] [Related]
20. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.
Otkjaer K; Kragballe K; Funding AT; Clausen JT; Noerby PL; Steiniche T; Iversen L
Br J Dermatol; 2005 Nov; 153(5):911-8. PubMed ID: 16225599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
